Model for End-Stage Liver Disease Exceptions in the Context of the French Model for End-Stage Liver Disease Score-Based Liver Allocation System

被引:67
作者
Francoz, Claire [1 ,8 ]
Belghiti, Jacques [2 ]
Castaing, Denis [3 ]
Chazouilleres, Olivier [4 ]
Duclos-Vallee, Jean-Charles [3 ]
Duvoux, Christophe [5 ]
Lerut, Jan [6 ]
Le Treut, Yves-Patrice [7 ]
Moreau, Richard [8 ]
Mandot, Ameet [1 ]
Pageaux, Georges [9 ]
Samuel, Didier [3 ]
Thabut, Dominique [10 ]
Valla, Dominique [1 ,8 ]
Durand, Francois [1 ,8 ]
机构
[1] Beaujon Hosp, Dept Hepatol, F-92110 Clichy, France
[2] Beaujon Hosp, Dept Hepatobiliary & Pancreat Surg, F-92110 Clichy, France
[3] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[4] St Antoine Hosp, Dept Hepatol, Paris, France
[5] Henri Mondor Hosp, Dept Hepatol, Creteil, France
[6] St Luc Univ Hosp, Dept Abdominal & Transplantat Surg, Brussels, Belgium
[7] Hosp Concept, Dept Digest Surg, Marseille, France
[8] Natl Inst Hlth & Med Res, U773, Bichat Beaujon Ctr Biomed Res CRB3, Paris, France
[9] St Eloi Hosp, Dept Hepatol, Montpellier, France
[10] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France
关键词
HEREDITARY HEMORRHAGIC TELANGIECTASIA; INTRAHEPATIC PORTOSYSTEMIC SHUNT; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; POLYTETRAFLUOROETHYLENE-COVERED STENT; NODULAR REGENERATIVE HYPERPLASIA; BUDD-CHIARI-SYNDROME; HEPATITIS-B-VIRUS; POLYCYSTIC LIVER; PORTOPULMONARY HYPERTENSION;
D O I
10.1002/lt.22363
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not significantly affect posttransplant survival. The MELD score can be used to optimize the allocation of allografts according to a sickest first policy. Most often, patients with small hepatocellular carcinomas (HCCs) and low MELD scores receive extra points, which allow them appropriate access to transplantation comparable to the access of patients with advanced cirrhosis and high MELD scores. In addition to patients with advanced cirrhosis and HCC, patients with a number of relatively uncommon conditions have low MELD scores and a poor prognosis in the short term without transplantation but derive excellent benefits from transplantation. These conditions, which correspond to the so-called MELD score exceptions, justify the allocation of a specific score for appropriate access to transplantation. Here we report the conclusions of the French consensus meeting. The goals of this meeting were (1) to identify which conditions merit MELD score exceptions, (2) to list the criteria needed for defining each of these conditions, and (3) to define a reasonable time interval for organ allocation for each MELD exception in the general context of organ shortages. MELD exceptions were discussed in an attempt to reconcile the concepts of transparency, equity, justice, and utility. Liver Transpl 17: 1137-1151, 2011. (C) 2011 AASLD.
引用
收藏
页码:1137 / 1151
页数:15
相关论文
共 123 条
[21]   Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation [J].
Charon, JPM ;
Alaeddin, FH ;
Pimpalwar, SA ;
Fay, DM ;
Olliff, SP ;
Jackson, RW ;
Edwards, RD ;
Robertson, IR ;
Rose, JD ;
Moss, JG .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (11) :1219-1230
[22]   Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study [J].
Colle, IO ;
Moreau, R ;
Godinho, E ;
Belghiti, J ;
Ettori, F ;
Cohen-Solal, A ;
Mal, H ;
Bernuau, J ;
Marty, J ;
Lebrec, D ;
Valla, D ;
Durand, F .
HEPATOLOGY, 2003, 37 (02) :401-409
[23]   THORACENTESIS - CLINICAL-VALUE, COMPLICATIONS, TECHNICAL PROBLEMS, AND PATIENT EXPERIENCE [J].
COLLINS, TR ;
SAHN, SA .
CHEST, 1987, 91 (06) :817-822
[24]   Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis [J].
D'Amico, G ;
Luca, A ;
Morabito, A ;
Miraglia, R ;
D'Amico, M .
GASTROENTEROLOGY, 2005, 129 (04) :1282-1293
[25]   Evolving consensus in portal hypertension - Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension [J].
de Franchis, R .
JOURNAL OF HEPATOLOGY, 2005, 43 (01) :167-176
[26]   Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension [J].
de Franchis, Roberto .
JOURNAL OF HEPATOLOGY, 2010, 53 (04) :762-768
[27]   Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C [J].
de Vera, M. E. ;
Dvorchik, I. ;
Tom, K. ;
Eghtesad, B. ;
Thai, N. ;
Shakil, O. ;
Marcos, A. ;
Demetris, A. ;
Jain, A. ;
Fung, J. J. ;
Ragni, M. V. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :2983-2993
[28]   Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients With Cirrhosis [J].
Dhanasekaran, Renumathy ;
West, Jonathan K. ;
Gonzales, Patrick C. ;
Subramanian, Ram ;
Parekh, Samir ;
Spivey, James R. ;
Martin, Louis G. ;
Kim, Hyun S. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (03) :635-641
[29]   Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus [J].
Duclos-Vallee, Jean-Charles ;
Feray, Cyrille ;
Sebagh, Mylene ;
Teicher, Elina ;
Roque-Afonso, Anne-Marie ;
Roche, Bruno ;
Azoulay, Daniel ;
Adam, Rene ;
Bismuth, Henri ;
Castaing, Denis ;
Vittecoq, Daniel ;
Satnuel, Didier .
HEPATOLOGY, 2008, 47 (02) :407-417
[30]   Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD [J].
Durand, F ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2005, 42 :S100-S107